These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33626320)

  • 1. Could sublingual vaccination be a viable option for the prevention of recurrent urinary tract infection in Canada? A systematic review of the current literature and plans for the future.
    Nickel JC; Saz-Leal P; Doiron RC
    Can Urol Assoc J; 2020 Aug; 14(8):281-287. PubMed ID: 33626320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness of a Sublingual Bacterial Vaccine for the Prophylaxis of Recurrent Urinary Tract Infections.
    Carrión-López P; Martínez-Ruiz J; Giménez-Bachs JM; Fernández-Anguita PJ; Díaz de Mera-Sánchez Migallón I; Legido-Gómez O; Rico-Marco S; Lorenzo-Sánchez MV; Salinas-Sánchez AS
    Urol Int; 2022; 106(7):730-736. PubMed ID: 35130558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects.
    Ramírez Sevilla C; Gómez Lanza E; Manzanera JL; Martín JAR; Sanz MÁB
    BMC Infect Dis; 2019 Oct; 19(1):901. PubMed ID: 31660885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary Analysis of Interstitial Cystitis/Bladder Pain Syndrome Patients Enrolled in a Recurrent Urinary Tract Infection Prevention Study Provides a Novel Paradigm for Etio-Pathogenesis and Practical Management of This Infection Phenotype.
    Nickel JC; Cotechini T; Doiron RC
    Pathogens; 2024 May; 13(5):. PubMed ID: 38787248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First experience in the UK of treating women with recurrent urinary tract infections with the bacterial vaccine Uromune
    Yang B; Foley S
    BJU Int; 2018 Feb; 121(2):289-292. PubMed ID: 29171130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of systemic estrogen for preventing urinary tract infections in postmenopausal women.
    Fox KA; Lokken EM; Reed SD; Rahn DD
    Menopause; 2021 May; 28(7):836-844. PubMed ID: 33973539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent urinary tract infection management and prevention techniques among a population-based cohort of women.
    Gleicher S; Sebesta EM; Kaufman MR; Dmochowski RR; Reynolds WS
    Neurourol Urodyn; 2023 Nov; 42(8):1676-1685. PubMed ID: 37670465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing Recurrent Urinary Tract Infections in Women with MV140 Impacts Personal Burden of Disease: Secondary Analyses of a Randomized Placebo-controlled Efficacy Study.
    Curtis Nickel J; Foley S; Yang B; Casanovas M; Caballero R; Diez-Rivero CM; Lorenzo-Gómez MF
    Eur Urol Open Sci; 2024 May; 63():96-103. PubMed ID: 38585593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of D-Mannose in the Prevention of Recurrent Uncomplicated Cystitis: State of the Art and Future Perspectives.
    De Nunzio C; Bartoletti R; Tubaro A; Simonato A; Ficarra V
    Antibiotics (Basel); 2021 Apr; 10(4):. PubMed ID: 33915821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for preventing recurrent urinary tract infection during pregnancy.
    Schneeberger C; Geerlings SE; Middleton P; Crowther CA
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009279. PubMed ID: 23152271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoactive Prophylaxis Protocol of Uncomplicated Recurrent Urinary Tract Infections in a Cohort of 1104 Women Treated with Uromune
    Ramírez Sevilla C; Gómez Lanza E; Puyol Pallàs M
    Life (Basel); 2024 Apr; 14(4):. PubMed ID: 38672735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women.
    Perrotta C; Aznar M; Mejia R; Albert X; Ng CW
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005131. PubMed ID: 18425910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of sublingual therapeutic vaccine with antibiotics for the prophylaxis of recurrent urinary tract infections.
    Lorenzo-Gómez MF; Padilla-Fernández B; García-Cenador MB; Virseda-Rodríguez ÁJ; Martín-García I; Sánchez-Escudero A; Vicente-Arroyo MJ; Mirón-Canelo JA
    Front Cell Infect Microbiol; 2015; 5():50. PubMed ID: 26090341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial Vaccines for the Management of Recurrent Urinary Tract Infections: A Systematic Review and Meta-analysis.
    Mak Q; Greig J; Dasgupta P; Malde S; Raison N
    Eur Urol Focus; 2024 Sep; 10(5):761-769. PubMed ID: 38644097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of recurrent urinary tract infections.
    Wagenlehner FM; Vahlensieck W; Bauer HW; Weidner W; Piechota HJ; Naber KG
    Minerva Urol Nefrol; 2013 Mar; 65(1):9-20. PubMed ID: 23538307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of uncomplicated recurrent urinary tract infections.
    Zare M; Vehreschild MJGT; Wagenlehner F
    BJU Int; 2022 Jun; 129(6):668-678. PubMed ID: 34741796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming challenges in the management of recurrent urinary tract infections.
    Cornelius SA; Basu U; Zimmern PE; De Nisco NJ
    Expert Rev Anti Infect Ther; 2024 Dec; 22(12):1157-1169. PubMed ID: 39387179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient prescribing and prophylactic antibiotic use for recurrent urinary tract infections in British Columbia, Canada.
    Saatchi A; Yoo JW; Marra F
    Can Urol Assoc J; 2021 Dec; 15(12):397-404. PubMed ID: 34171208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the bacterial vaccine Solco-Urovac® in treatment and prevention of recurrent urinary tract infections of bacterial origin.
    Kochiashvili D; Khuskivadze A; Kochiashvili G; Koberidze G; Kvakhajelidze V
    Georgian Med News; 2014 Jun; (231):11-6. PubMed ID: 25020163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
    Ejrnæs K
    Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.